Related references
Note: Only part of the references are listed.Molecular mechanism and pharmacokinetics of flavonoids in the treatment of resistant EGF receptor-mutated non-small-cell lung cancer: A narrative review
Xuewen Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer
Yetirajam Rajesh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
Eun Jin Sun et al.
BIOMEDICINES (2021)
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
Agrimol B present in Agrimonia pilosa Ledeb impedes cell cycle progression of cancer cells through G0 state arrest
Su Su Thae Hnit et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Sec62 promotes pro-angiogenesis of hepatocellular carcinoma cells under hypoxia
Yongbin Meng et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2021)
Kaempferol inhibits the cell migration of human hepatocellular carcinoma cells by suppressing MMP-9 and Akt signaling
Po-Chung Ju et al.
ENVIRONMENTAL TOXICOLOGY (2021)
EGFR activation limits the response of liver cancer to lenvatinib
Haojie Jin et al.
NATURE (2021)
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
Ji Lin et al.
CELL DEATH & DISEASE (2020)
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
Maria A. Rodriguez-Hernandez et al.
CELL DEATH & DISEASE (2020)
NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β-catenin pathway
Yonggang Ren et al.
JOURNAL OF CANCER (2020)
Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach
Bhagyalakshmi Nair et al.
ADVANCED PHARMACEUTICAL BULLETIN (2020)
Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway
Hongyan Wu et al.
MOLECULES (2019)
MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1
Pei-Wei Yang et al.
PHYTOMEDICINE (2019)
Quercetin inhibits growth of hepatocellular carcinoma by apoptosis induction in part via autophagy stimulation in mice
Yi Ji et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
Liwei Wu et al.
CANCER MEDICINE (2019)
Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats
Yasmin Ahmed Salama et al.
LIFE SCIENCES (2019)
Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
Xiwen Liao et al.
JOURNAL OF CANCER (2019)
Traditional Herbal Medicine Prevents Postoperative Recurrence of Small Hepatocellular Carcinoma: A Randomized Controlled Study
Xiao-feng Zhai et al.
CANCER (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma
Zhikui Liu et al.
THERANOSTICS (2018)
A scored human protein-protein interaction network to catalyze genomic interpretation
Taibo Li et al.
NATURE METHODS (2017)
Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells
Ke-Wei Ren et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Identification of WT1 as determinant of heptatocellular carcinoma and its inhibition by Chinese herbal medicine Salvia chinensis Benth and its active ingredient protocatechualdehyde
Ning Wang et al.
ONCOTARGET (2017)
Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma
Zhijia Cao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
Pengfei Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
P-F Zhang et al.
CELL DEATH & DISEASE (2016)
Antitumor immunostimulatory activity of polysaccharides from Salvia chinensis Benth
Guangwen Shu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Herbal medicine Guan Chang Fu Fang enhances 5-fluorouracil cytotoxicity and affects drug-associated genes in human colorectal carcinoma cells
Chen Yu et al.
ONCOLOGY LETTERS (2015)
The Global Burden of Liver Disease: The Major Impact of China
Fu-Sheng Wang et al.
HEPATOLOGY (2014)
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
David Gfeller et al.
NUCLEIC ACIDS RESEARCH (2014)
Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells
Wei Gu et al.
ONCOLOGY REPORTS (2014)
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Jinlong Ru et al.
JOURNAL OF CHEMINFORMATICS (2014)
Anti-fatty liver effects of oils from Zingiber officinale and Curcuma longa on ethanol-induced fatty liver in rats
Sarah Onyenibe Nwozo et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2014)
Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities
Chang-qing Zhao et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2014)
Bioavailability and bioequivalence in drug development
Shein-Chung Chow
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL STATISTICS (2014)
Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease
Weiyang Tao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Moscatilin Inhibits Lung Cancer Cell Motility and Invasion via Suppression of Endogenous Reactive Oxygen Species
Akkarawut Kowitdamrong et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
Augusto Villanueva et al.
CLINICAL CANCER RESEARCH (2012)
FAK is involved in invasion and metastasis of hepatocellular carcinoma
Jing-Song Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
SRC-3Δ4 Mediates the Interaction of EGFR with FAK to Promote Cell Migration
Weiwen Long et al.
MOLECULAR CELL (2010)
BioGRID: a general repository for interaction datasets
Chris Stark et al.
NUCLEIC ACIDS RESEARCH (2006)
An automated method for finding molecular complexes in large protein interaction networks
GD Bader et al.
BMC BIOINFORMATICS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Share Paper
